Section 6

Compilation des études démontrant l’efficacité et l’innocuité de l’alimentation faible en glucides pour la perte de poids

Randomised Controlled Trials (RCTs) – Public Health Collaboration (phcuk.org)

Suggestion de lecture sur l’alimentation optimale dans un contexte de diabète gestationnel

Références

https://www.diabetes.co.uk/keto/

American diabetes association. (2019). Lifestyle management: standards of medical car in diabetes. Diabetes care 2019;42(suppl. 1):s4

https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/8b4a8a54-f6b0-4ce6-bfc2-159686db7983.pdf

Diabetes Canada Position Statement on Low-Carbohydrate Diets for Adults With Diabetes: A Rapid Review. (2020). Canadian journal of diabetes, 44(4), 295–299.

Murdoch, C., Unwin, D., Cavan, D., Cucuzzella, M., & Patel, M. (2019). Adapting diabetes medication for low carbohydrate management of type 2 diabetes: a practical guide. The British journal of general practice : the journal of the Royal College of General Practitioners, 69(684), 360–361. https://doi.org/10.3399/bjgp19X704525

Cucuzzella, M., Riley, K., & Isaacs, D. (2021). Adapting Medication for Type 2 Diabetes to a Low Carbohydrate Diet. Frontiers in nutrition, 8, 688540. https://doi.org/10.3389/fnut.2021.688540

Feinman, R. D., Pogozelski, W. K., Astrup, A., Bernstein, R. K., Fine, E. J., Westman, E. C., Accurso, A., Frassetto, L., Gower, B. A., McFarlane, S. I., Nielsen, J. V., Krarup, T., Saslow, L., Roth, K. S., Vernon, M. C., Volek, J. S., Wilshire, G. B., Dahlqvist, A., Sundberg, R., Childers, A., … Worm, N. (2015). Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition (Burbank, Los Angeles County, Calif.), 31(1), 1–13. https://doi-org.acces.bibl.ulaval.ca/10.1016/j.nut.2014.06.011

Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK, et al. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. The Journal of clinical endocrinology and metabolism. 2022;107(1):1-9. Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia. 2021;64(11):2359-66.

McKenzie AL, Hallberg SJ, Creighton BC, Volk BM, Link TM, Abner MK, Glon RM, McCarter JP, Volek JS, Phinney SD, A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes, JMIR Diabetes 2017;2(1):e5

Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, Hazbun TL, Volk BM, McCarter JP, Phinney SD, Volek JS. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018 Apr;9(2):583-612.

Athinarayanan SJ, Hallberg SJ, McKenzie AL, Lechner K, King S, McCarter JP, Volek JS, Phinney SD, Krauss RM. Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes. Cardiovasc Diabetol. 2020 Dec 8;19(1):208.

Wheatley, S. D., Deakin, T. A., Arjomandkhah, N. C., Hollinrake, P. B., & Reeves, T. E. (2021). Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes-A Narrative Review. Frontiers in nutrition, 8, 687658.

Rehackova L, Rodrigues AM, Thom G, Brosnahan N, Barnes AC, McCombie L, Leslie WS, Zhyzhneuskaya S, Peters C, Adamson AJ, Lean MEJ, Taylor R, Sniehotta FF. Participant experiences in the Diabetes REmission Clinical Trial (DiRECT). Diabet Med. 2022 Jan;39(1):e14689.

North S, Zinn C, Crofts C. Hyperinsulinemia during pregnancy across varying degrees of glucose tolerance: An examination of the Kraft database. J Obstet Gynaecol Res. 2021 May;47(5):1719-1726.

Song H, Yu Z, Li P, Wang Y, Shi Y. HOMA-IR for predicting clinical pregnancy rate during IVF. Gynecol Endocrinol. 2022 Jan;38(1):33-38.

Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007 Dec;50(4):938-48.

Widjaja NA, Irawan R, Hanindita MH, Ugrasena I, Handajani R. METS-IR vs. HOMA-AD and Metabolic Syndrome in Obese Adolescents. J Med Invest. 2023;70(1.2):7-16.